• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在铜螯合剂诱导的小鼠模型中,溶血磷脂酸受体5信号传导参与了多发性硬化介导的神经性疼痛。

LPA5 signaling is involved in multiple sclerosis-mediated neuropathic pain in the cuprizone mouse model.

作者信息

Tsukahara Ryoko, Yamamoto Shinji, Yoshikawa Keisuke, Gotoh Mari, Tsukahara Tamotsu, Neyama Hiroyuki, Ishii Satoshi, Akahoshi Noriyuki, Yanagida Keisuke, Sumida Hayakazu, Araki Masatake, Araki Kimi, Yamamura Ken-Ichi, Murakami-Murofushi Kimiko, Ueda Hiroshi

机构信息

Department of Pharmacology and Therapeutic Innovation, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Department of Pharmacology, Faculty of Medicine, Saitama Medical University, Saitama, Japan.

出版信息

J Pharmacol Sci. 2018 Feb;136(2):93-96. doi: 10.1016/j.jphs.2018.01.001. Epub 2018 Feb 2.

DOI:10.1016/j.jphs.2018.01.001
PMID:29409686
Abstract

Lysophosphatidic acid (LPA) and LPA1 receptor signaling play a crucial role in the initiation of peripheral nerve injury-induced neuropathic pain through the alternation of pain-related genes/proteins expression and demyelination. However, LPA and its signaling in the brain are still poorly understood. In the present study, we revealed that the LPA5 receptor expression in corpus callosum elevated after the initiation of demyelination, and the hyperalgesia through Aδ-fibers following cuprizone-induced demyelination was mediated by LPA5 signaling. These data suggest that LPA5 signaling may play a key role in the mechanisms underlying neuropathic pain following demyelination in the brain.

摘要

溶血磷脂酸(LPA)和LPA1受体信号传导通过改变疼痛相关基因/蛋白质表达和脱髓鞘在周围神经损伤诱导的神经性疼痛的起始中起关键作用。然而,LPA及其在大脑中的信号传导仍知之甚少。在本研究中,我们发现胼胝体中的LPA5受体表达在脱髓鞘开始后升高,并且铜离子螯合剂诱导脱髓鞘后通过Aδ纤维的痛觉过敏由LPA5信号传导介导。这些数据表明,LPA5信号传导可能在脑脱髓鞘后神经性疼痛的潜在机制中起关键作用。

相似文献

1
LPA5 signaling is involved in multiple sclerosis-mediated neuropathic pain in the cuprizone mouse model.在铜螯合剂诱导的小鼠模型中,溶血磷脂酸受体5信号传导参与了多发性硬化介导的神经性疼痛。
J Pharmacol Sci. 2018 Feb;136(2):93-96. doi: 10.1016/j.jphs.2018.01.001. Epub 2018 Feb 2.
2
Analgesic effects of novel lysophosphatidic acid receptor 5 antagonist AS2717638 in rodents.新型溶血磷脂酸受体 5 拮抗剂 AS2717638 在啮齿类动物中的镇痛作用。
Neuropharmacology. 2017 Nov;126:97-107. doi: 10.1016/j.neuropharm.2017.08.032. Epub 2017 Aug 30.
3
Involvement of LPA1 receptor signaling in cerebral ischemia-induced neuropathic pain.LPA1 受体信号通路参与脑缺血诱导的神经病理性疼痛。
Neuroscience. 2013 Apr 3;235:10-5. doi: 10.1016/j.neuroscience.2013.01.005. Epub 2013 Jan 11.
4
Targeted deletion of LPA5 identifies novel roles for lysophosphatidic acid signaling in development of neuropathic pain.靶向敲除 LPA5 鉴定出溶血磷脂酸信号在神经病理性疼痛发展中的新作用。
J Biol Chem. 2012 May 18;287(21):17608-17617. doi: 10.1074/jbc.M111.330183. Epub 2012 Mar 29.
5
Lysophosphatidic acid-induced itch is mediated by signalling of LPA receptor, phospholipase D and TRPA1/TRPV1.溶血磷脂酸诱导的瘙痒是由溶血磷脂酸受体、磷脂酶D和瞬时受体电位锚蛋白1/瞬时受体电位香草酸亚型1的信号传导介导的。
J Physiol. 2017 Apr 15;595(8):2681-2698. doi: 10.1113/JP273961. Epub 2017 Mar 22.
6
Lysophosphatidic acid and its receptors LPA1 and LPA3 mediate paclitaxel-induced neuropathic pain in mice.溶血磷脂酸及其受体LPA1和LPA3介导紫杉醇诱导的小鼠神经性疼痛。
Mol Pain. 2014 Nov 19;10:71. doi: 10.1186/1744-8069-10-71.
7
Lysophosphatidic acid receptors (LPARs): Potential targets for the treatment of neuropathic pain.溶血磷脂酸受体(LPARs):治疗神经性疼痛的潜在靶点。
Neuropharmacology. 2017 Feb;113(Pt B):608-617. doi: 10.1016/j.neuropharm.2016.04.002. Epub 2016 Apr 5.
8
Lysophosphatidic acid as the initiator of neuropathic pain.溶血磷脂酸作为神经病理性疼痛的启动子。
Biol Pharm Bull. 2011;34(8):1154-8. doi: 10.1248/bpb.34.1154.
9
Lysophosphatidic Acid Receptor 1- and 3-Mediated Hyperalgesia and Hypoalgesia in Diabetic Neuropathic Pain Models in Mice.溶血磷脂酸受体 1 和 3 介导的糖尿病神经病理性疼痛模型中小鼠的痛觉过敏和痛觉减退。
Cells. 2020 Aug 16;9(8):1906. doi: 10.3390/cells9081906.
10
Loss of spinal substance P pain transmission under the condition of LPA1 receptor-mediated neuropathic pain.在溶血磷脂酸1(LPA1)受体介导的神经性疼痛条件下脊髓P物质痛觉传递的丧失
Mol Pain. 2006 Aug 16;2:25. doi: 10.1186/1744-8069-2-25.

引用本文的文献

1
Unraveling the Role of Autotaxin and Lysophosphatidic Acid in Alzheimer's Disease: From Molecular Mechanisms to Therapeutic Potential.解析自分泌运动因子和溶血磷脂酸在阿尔茨海默病中的作用:从分子机制到治疗潜力
Int J Mol Sci. 2025 Jul 23;26(15):7068. doi: 10.3390/ijms26157068.
2
Emerging roles of lysophosphatidic acid receptor subtype 5 (LPAR5) in inflammatory diseases and cancer.溶血磷脂酸受体亚型 5(LPAR5)在炎症性疾病和癌症中的新兴作用。
Pharmacol Ther. 2023 May;245:108414. doi: 10.1016/j.pharmthera.2023.108414. Epub 2023 Apr 13.
3
Sex Differences in the Behavioural Aspects of the Cuprizone-Induced Demyelination Model in Mice.
小鼠中铜离子螯合剂诱导的脱髓鞘模型行为学方面的性别差异
Brain Sci. 2022 Dec 8;12(12):1687. doi: 10.3390/brainsci12121687.
4
An LPAR -antagonist that reduces nociception and increases pruriception.一种降低伤害感受并增加瘙痒感受的LPAR拮抗剂。
Front Pain Res (Lausanne). 2022 Jul 26;3:963174. doi: 10.3389/fpain.2022.963174. eCollection 2022.
5
Dual Mechanism of Action of Curcumin in Experimental Models of Multiple Sclerosis.姜黄素在多发性硬化症实验模型中的双重作用机制。
Int J Mol Sci. 2022 Aug 4;23(15):8658. doi: 10.3390/ijms23158658.
6
TNFα in MS and Its Animal Models: Implications for Chronic Pain in the Disease.肿瘤坏死因子α在多发性硬化症及其动物模型中的作用:对该疾病慢性疼痛的影响
Front Neurol. 2021 Dec 6;12:780876. doi: 10.3389/fneur.2021.780876. eCollection 2021.
7
Receptor for Advanced Glycation End Products Is Involved in LPA-Mediated Brain Damage after a Transient Ischemic Stroke.晚期糖基化终末产物受体参与短暂性脑缺血发作后溶血磷脂酸介导的脑损伤。
Life (Basel). 2021 Jan 22;11(2):80. doi: 10.3390/life11020080.
8
Lysophosphatidic Acid Receptor 5 Plays a Pathogenic Role in Brain Damage after Focal Cerebral Ischemia by Modulating Neuroinflammatory Responses.溶血磷脂酸受体 5 通过调节神经炎症反应在局灶性脑缺血后脑损伤中发挥致病作用。
Cells. 2020 Jun 10;9(6):1446. doi: 10.3390/cells9061446.
9
Lysophosphatidic Acid Receptors: Biochemical and Clinical Implications in Different Diseases.溶血磷脂酸受体:在不同疾病中的生化及临床意义
J Cancer. 2020 Mar 15;11(12):3519-3535. doi: 10.7150/jca.41841. eCollection 2020.
10
Small-Molecule Lysophosphatidic Acid Receptor 5 (LPAR5) Antagonists: Versatile Pharmacological Tools to Regulate Inflammatory Signaling in BV-2 Microglia Cells.小分子溶血磷脂酸受体5(LPAR5)拮抗剂:调节BV-2小胶质细胞炎症信号的多功能药理学工具。
Front Cell Neurosci. 2019 Nov 29;13:531. doi: 10.3389/fncel.2019.00531. eCollection 2019.